J9201 Insurance Policy Changes

HCPCS J9201 is officially defined as "Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg." HCPCS J9201 is referenced in 3 tracked payer policy changes from UnitedHealthcare, Florida Blue, and 1 other payer. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS J9201 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.